Cargando…
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer India
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119228/ https://www.ncbi.nlm.nih.gov/pubmed/35076895 http://dx.doi.org/10.1007/s12072-022-10301-2 |
| _version_ | 1784710660447272960 |
|---|---|
| author | Lau, George Yu, Ming-Lung Wong, Grace Thompson, Alexander Ghazinian, Hasmik Hou, Jin-Lin Piratvisuth, Teerha Jia, Ji-Dong Mizokami, Masashi Cheng, Gregory Chen, Guo-Feng Liu, Zhen-Wen Baatarkhuu, Oidov Cheng, Ann Lii Ng, Woon Leung Lau, Patrick Mok, Tony Chang, Jer-Ming Hamid, Saeed Dokmeci, A. Kadir Gani, Rino A. Payawal, Diana A. Chow, Pierce Park, Joong-Won Strasser, Simone I. Mohamed, Rosmawaiti Win, Khin Maung Tanwandee, Tawesak Sarin, Shiv Kumar Omata, Masao |
| author_facet | Lau, George Yu, Ming-Lung Wong, Grace Thompson, Alexander Ghazinian, Hasmik Hou, Jin-Lin Piratvisuth, Teerha Jia, Ji-Dong Mizokami, Masashi Cheng, Gregory Chen, Guo-Feng Liu, Zhen-Wen Baatarkhuu, Oidov Cheng, Ann Lii Ng, Woon Leung Lau, Patrick Mok, Tony Chang, Jer-Ming Hamid, Saeed Dokmeci, A. Kadir Gani, Rino A. Payawal, Diana A. Chow, Pierce Park, Joong-Won Strasser, Simone I. Mohamed, Rosmawaiti Win, Khin Maung Tanwandee, Tawesak Sarin, Shiv Kumar Omata, Masao |
| author_sort | Lau, George |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9119228 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer India |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91192282022-05-20 Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy Lau, George Yu, Ming-Lung Wong, Grace Thompson, Alexander Ghazinian, Hasmik Hou, Jin-Lin Piratvisuth, Teerha Jia, Ji-Dong Mizokami, Masashi Cheng, Gregory Chen, Guo-Feng Liu, Zhen-Wen Baatarkhuu, Oidov Cheng, Ann Lii Ng, Woon Leung Lau, Patrick Mok, Tony Chang, Jer-Ming Hamid, Saeed Dokmeci, A. Kadir Gani, Rino A. Payawal, Diana A. Chow, Pierce Park, Joong-Won Strasser, Simone I. Mohamed, Rosmawaiti Win, Khin Maung Tanwandee, Tawesak Sarin, Shiv Kumar Omata, Masao Hepatol Int Correction Springer India 2022-01-25 /pmc/articles/PMC9119228/ /pubmed/35076895 http://dx.doi.org/10.1007/s12072-022-10301-2 Text en © Asian Pacific Association for the Study of the Liver 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correction Lau, George Yu, Ming-Lung Wong, Grace Thompson, Alexander Ghazinian, Hasmik Hou, Jin-Lin Piratvisuth, Teerha Jia, Ji-Dong Mizokami, Masashi Cheng, Gregory Chen, Guo-Feng Liu, Zhen-Wen Baatarkhuu, Oidov Cheng, Ann Lii Ng, Woon Leung Lau, Patrick Mok, Tony Chang, Jer-Ming Hamid, Saeed Dokmeci, A. Kadir Gani, Rino A. Payawal, Diana A. Chow, Pierce Park, Joong-Won Strasser, Simone I. Mohamed, Rosmawaiti Win, Khin Maung Tanwandee, Tawesak Sarin, Shiv Kumar Omata, Masao Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy |
| title | Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy |
| title_full | Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy |
| title_fullStr | Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy |
| title_full_unstemmed | Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy |
| title_short | Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy |
| title_sort | correction to: apasl clinical practice guideline on hepatitis b reactivation related to the use of immunosuppressive therapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119228/ https://www.ncbi.nlm.nih.gov/pubmed/35076895 http://dx.doi.org/10.1007/s12072-022-10301-2 |
| work_keys_str_mv | AT laugeorge correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT yuminglung correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT wonggrace correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT thompsonalexander correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT ghazinianhasmik correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT houjinlin correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT piratvisuthteerha correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT jiajidong correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT mizokamimasashi correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT chenggregory correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT chenguofeng correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT liuzhenwen correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT baatarkhuuoidov correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT chengannlii correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT ngwoonleung correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT laupatrick correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT moktony correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT changjerming correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT hamidsaeed correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT dokmeciakadir correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT ganirinoa correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT payawaldianaa correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT chowpierce correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT parkjoongwon correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT strassersimonei correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT mohamedrosmawaiti correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT winkhinmaung correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT tanwandeetawesak correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT sarinshivkumar correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy AT omatamasao correctiontoapaslclinicalpracticeguidelineonhepatitisbreactivationrelatedtotheuseofimmunosuppressivetherapy |